US drug approvals
12 approvals with a product on the US market
- Nicardipine Hydrochloride In 0.86% Sodium Chloride, Nicardipine Hydrochloride In 0.83% Sodium Chloride ANDA203978 · approved 17 Apr 2024
- Acetaminophen ANDA215403 · approved 3 May 2023
- Norepinephrine Bitartrate In 0.9% Sodium Chloride NDA215700 · approved 15 Sep 2022
- Midazolam In 0.9% Sodium Chloride NDA211844 · approved 22 Mar 2021
- Metronidazole In Plastic Container ANDA206191 · approved 25 Feb 2019
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
